IDH1 and central nervous system cancer: However, the proportion of IDH1/2-wild-type gliomas in the thalamus–basal ganglia (13.9%) and the infratentorial region (14.5%) was significantly higher than that of IDH1/2-mutant gliomas (3.3% and 3.2%, respectively).